Juul Ban Will Send Altria’s Strategy, and $13 Billion, Up in Smoke

Altria Group disastrous investment in Juul Labs is taking another turn for the worse.

On Wednesday, The Wall Street Journal reported that the Food and Drug Administration is preparing to remove Juul e-cigarettes from the U.S. market. Banning Juul in the U.S., where it was on track to make 94% of its revenue this year, would put the business in serious jeopardy.